All but 14 of the 45 universities placed under investigation for participating in the PhD Project and allegedly violating civil rights law have agreed to cease partnering with the organization, the ...

This voice experience is generated by AI. Learn more. This voice experience is generated by AI. Learn more. Voice AI using Small Language Models is becoming a major market requirement for phones, ...

The CAPP will provide purified recycled water that is injected into groundwater basins, stored for several months and then pumped out for drinking water purposes. Credit: Courtesy photo After more ...

Pioneer today announced a new in-dash receiver that supports Dolby Atmos audio playback within Apple CarPlay, extending the feature into the aftermarket category for the first time. The system uses a ...

To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Virginia Tech is driving the future of economic growth and ...

Spring Boot is one of the most popular and accessible web development frameworks in the world. Find out what it’s about, with this quick guide to web development with Spring Boot. Spring’s most ...

In an economic boon for the city, a massive plot of empty fields near the regional wastewater plant in North San Jose could become a new data center and advanced manufacturing campus, potentially ...

Want to watch a movie with your family or friends, but still allow each person to use their own audio device? Microsoft is previewing a new feature that will allow Windows 11 users to share audio over ...

The tech industry is on a tear, building data centers for AI as quickly as they can buy up the land. The sky-high energy costs and logistical headaches of managing all those data centers have prompted ...

Amazon and Energy Northwest advance Cascade Advanced Energy Facility near Richland Project will deploy X-energy Xe-100 advanced small nuclear reactors Education, simulator training planned for ...

In August, Zongertinib received FDA approval for previously treated HER2-mutant NSCLC. It now shows efficacy in first-line treatment, with a 77% objective response rate and 96% disease control rate.